These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1460474)

  • 1. Cost efficient sampling design for quality control of a birth defects registry.
    Hahn JA; Schulman J
    J Clin Epidemiol; 1992 Dec; 45(12):1371-5. PubMed ID: 1460474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality control of birth defect registry data: a case study.
    Schulman J; Hahn JA
    Public Health Rep; 1993; 108(1):91-8. PubMed ID: 8434104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to achieve sustainability and quality in birth defects registries: the experience of the National Registry of Congenital Anomalies of Argentina.
    Groisman B; Bidondo MP; Gili JA; Barbero P; Liascovich R
    J Registry Manag; 2013; 40(1):29-31. PubMed ID: 23778694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing and testing a cost data collection instrument for noncommunicable disease registry planning.
    Subramanian S; Tangka F; Edwards P; Hoover S; Cole-Beebe M
    Cancer Epidemiol; 2016 Dec; 45 Suppl 1(Suppl 1):S4-S12. PubMed ID: 27726980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Texas Birth Defects Registry: an active surveillance system.
    Miller E
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):787-92. PubMed ID: 17094140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing of National Birth Defects Registry in Thailand.
    Pangkanon S; Sawasdivorn S; Kuptanon C; Chotigeat U; Vandepitte W
    J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S182-8. PubMed ID: 25391192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological issues in setting up a surveillance system for birth defects in India.
    Suresh S; Thangavel G; Sujatha J; Indrani S
    Natl Med J India; 2005; 18(5):259-62. PubMed ID: 16433142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of DNA sample collection into a multi-site birth defects case-control study.
    Rasmussen SA; Lammer EJ; Shaw GM; Finnell RH; McGehee RE; Gallagher M; Romitti PA; Murray JC;
    Teratology; 2002 Oct; 66(4):177-84. PubMed ID: 12353214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving case ascertainment of a population-based birth defects registry in New York State using hospital discharge data.
    Wang Y; Sharpe-Stimac M; Cross PK; Druschel CM; Hwang SA
    Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):663-8. PubMed ID: 16240383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of cancer registry operations: Impact of volume on cost per case for core and enhanced registry activities.
    Subramanian S; Tangka FK; Beebe MC; Trebino D; Weir HK; Babcock F
    Eval Program Plann; 2016 Apr; 55():1-8. PubMed ID: 26702880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Michigan Birth Defects Registry: development and operation.
    Hogan JG
    J AHIMA; 1994 Jun; 65(6):38-40. PubMed ID: 10134107
    [No Abstract]   [Full Text] [Related]  

  • 12. [Using hospital discharge records, birth certificates and a birth defects registry for epidemiological and public health purposes: experience in Emilia-Romagna region (northern Italy)].
    Astolfi G; Bianchi F; Lupi C; Napoli N; Neville A; Verdini E; Verzola A; Calzolari E
    Epidemiol Prev; 2013; 37(4-5):279-88. PubMed ID: 24293493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.
    Ephross SA; Sinclair SM
    Headache; 2014; 54(7):1158-72. PubMed ID: 24805878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model to determine the optimal sampling schedule of diet components.
    St-Pierre NR; Cobanov B
    J Dairy Sci; 2007 Dec; 90(12):5383-94. PubMed ID: 18024729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prevention of neural tube defects with folate in Western Australia: the value of the Western Australian Birth Defects Registry.
    Bower C
    Congenit Anom (Kyoto); 2006 Jun; 46(2):118-21. PubMed ID: 16732771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Registry data quality improvement by identifying discrepancies between assigned codes and text descriptions of birth defects.
    Richardson SD; Fox DJ; Wittman B
    J Registry Manag; 2013; 40(4):165-7. PubMed ID: 24625769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurements of birth defect prevalence: which is most useful as a comparator group for pharmaceutical pregnancy registries?
    Scheuerle A; Vannappagari VX; Miller MK
    Birth Defects Res A Clin Mol Teratol; 2009 Jul; 85(7):611-20. PubMed ID: 19215016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Registry to referral: using birth defects registries to refer infants and toddlers for early intervention services.
    Farel AM; Meyer RE; Hicken M; Edmonds LD
    Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):647-50. PubMed ID: 14703788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Difficult Decisions in Public Health Surveillance: Striking the Right Balance between Timeliness and Completeness.
    Salemi JL; Tanner JP; Anjohrin SB; Rutkowski RE; Correia JA; Watkins SM; Kirby RS
    J Registry Manag; 2015; 42(2):48-61. PubMed ID: 26360106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Under-reporting of major birth defects in Northwest Russia: a registry-based study.
    Kovalenko AA; Brenn T; Odland JØ; Nieboer E; Krettek A; Anda EE
    Int J Circumpolar Health; 2017; 76(1):1366785. PubMed ID: 28853333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.